المؤلفون: Semu M; Addis Ababa Health Bureau, Addis Ababa, Ethiopia., Fenta TG; Social and Administrative Pharmacy Working Group, Department of Pharmaceutics and Social Pharmacy, College of Health Sciences, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia. tgedif@gmail.com., Medhin G; Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia., Assefa D; KNCV TB Care I-Ethiopia, Addis Ababa, Ethiopia.

المصدر: BMC infectious diseases [BMC Infect Dis] 2017 Jan 03; Vol. 17 (1), pp. 5. Date of Electronic Publication: 2017 Jan 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Acquired Immunodeficiency Syndrome/*drug therapy , Antitubercular Agents/*therapeutic use , HIV Infections/*drug therapy , Isoniazid/*therapeutic use , Tuberculosis/*prevention & control, Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/epidemiology ; Adult ; Aged ; Antiretroviral Therapy, Highly Active ; Chemoprevention/methods ; Cohort Studies ; Ethiopia/epidemiology ; Female ; HIV Infections/complications ; HIV Infections/epidemiology ; Health Facilities/statistics & numerical data ; Humans ; Incidence ; Male ; Middle Aged ; Public Health/statistics & numerical data ; Retrospective Studies ; Risk Factors ; Treatment Outcome ; Tuberculosis/complications ; Tuberculosis/epidemiology ; Young Adult